| Identification | Back Directory | [Name]
(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID
| [CAS]
114457-94-2 | [Synonyms]
N-PyrazinyL
Bortezomib INT
Bortezomib INT B
Bortezomib impurity B
N-(2-pyrazinylcarbonyl)-
Bortezomib Acid Impurity
Bortezomib Intermediate 2
Bortezomib USP Impurity D
(S)-3-Phenyl-2-(pyrazine-2-carbox
N-Pyrazinylcarbonyl-L-phenylalanine
(pyrazine-2-carbonyl)-L-phenylalanine
N-(2-Pyrazinylcarbonyl)-L-phenylalanine
L-Phenylalanine, N-(2-pyrazinylcarbonyl)-
Bortezomib Related Compund D/ Bortezomib Acid Analog
(S)-3-Phenyl-2-(pyrazine-2-carboxaMido)propanoic acid
(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid
2-[[oxo(2-pyrazinyl)methyl]amino]-3-phenylpropanoic acid
N-(Pyrazinylcarbonyl)-L-phenylalanine
(S)-3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic acid
(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID
Bortezomib impurity 12/((S)-3-Phenyl-2-(pyrazine-2-carbonylamino)propanoic Acid
BortezoMib IMpurity B ((S)-3-Phenyl-2-(pyrazine-2-carbonylaMino)propanoic Acid)
(S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic acid (Bortezomib Impurity)
(R)-3-methyl-1-((3aS,4S,6S,7aS)-3a,5,5-
trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-
amine
N-((S)-1-(((S)-3-methyl-1-((3aR,4R,6R,7aS)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3- phenylpropan-2-yl)pyrazine-2-carboxamide | [Molecular Formula]
C14H13N3O3 | [MDL Number]
MFCD09800536 | [MOL File]
114457-94-2.mol | [Molecular Weight]
271.271 |
| Chemical Properties | Back Directory | [Melting point ]
166-169℃ | [Boiling point ]
573.8±50.0 °C(Predicted) | [density ]
1.323 | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO, Methanol (Sparingly) | [form ]
Solid | [pka]
13.93±0.46(Predicted) | [color ]
White to Light Beige |
| Hazard Information | Back Directory | [Chemical Properties]
(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID is Light Beige Solid
| [Uses]
(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID is used for the synthesis of Bortezomib (B675700) from L-phenylalanine via dipeptidyl boronic acid ester intermediates.
|
|
|